세계의 락토페린(Lactoferrin) 시장 규모 : 기능별, 용도별, 지역 범위별 및 예측

Lactoferrin Market Size And Forecast

Lactoferrin Market size was valued at USD 2.06 Billion in 2024 and is projected to reach USD 4.49 Billion by 2032, growing at a CAGR of 7.9% from 2026 to 2032.

The increased consumer awareness of health and diet, as well as the rising occurrence of skin-related health issues, are likely to drive demand. Lactoferrin is thought to offer antiviral, antibacterial, antiparasitic, catalytic, and anti-allergic activities and qualities, which will increase product demand in the pharmaceutical and personal care sectors. Acne is the most common skin problem in the United States, impacting 40 to 50 million individuals each year, according to the American Academy of Dermatology. The Global Lactoferrin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Lactoferrin Market Definition

Lactoferrin is a nutritional supplement derived from milk. Lactoferrin is extracted from bovine milk and then mixed into a variety of commercial food products, including personal care items, infant formula, toothpaste, and nutraceuticals. Temperature, as well as physical and chemical restrictions, can trigger conformational changes in this multi-function protein. To avoid denaturation, the lactoferrin crude extract and process factors for lactoferrin-containing food items should be enhanced and optimized.

Among other things, it can assist with stomach and intestinal ulcers, diarrhea, and hepatitis C. It also acts as an antioxidant, which protects against bacterial and viral illnesses. It provides several health advantages for the body, including tissue damage prevention, cancer prevention, immune response activation, and other benefits. It is safe to consume, but excessive doses might have negative consequences. It is readily accessible in stores and online. It is most often found as a powder. Lactoferrin has antiviral, antibacterial, anti-carcinogenic, and anti-inflammatory properties. The protein's antibacterial and antifungal activities serve largely as a defense mechanism in the body. Lactoferrin is antibacterial and antifungal, making it suitable for human newborns.

Global Lactoferrin Market Overview

Acne is becoming more common in developed countries such as the United States, Canada, and Germany, and confirmed testimonies and study findings for lactoferrin-induced acne therapy are likely to drive growth opportunities for product producers throughout the projection period. The worldwide personal care sector is worth billions of dollars and is shifting away from traditional brick-and-mortar businesses and towards niche and internet retailers. Women of all ages prefer a cross-channel purchase method, where they visit online portals to learn about the goods before purchasing from an offline retail location.

Consumer awareness as a result of brand owners' product marketing operations, along with a preference for organic products with fewer side effects and improved efficiency, is predicted to boost product demand even further. Lactoferrin is widely used in the reduction of dermal immune response and wound healing by activating connective tissue with epidermal cells and rebuilding the skin. Its anti-inflammatory properties help to prevent the production of bigger zits and cysts. Lactoferrin has been shown in several clinical trials to be useful in the treatment and prevention of gastrointestinal inflammatory diseases.

Rising consumer knowledge about gut health, along with rising product demand to avoid irritable bowel movement and bloating, as well as to reduce intestinal inflammation, is expected to drive the expansion of the Lactoferrin Market throughout the projected period. However, negative effects associated with lactoferrin use, such as diarrhea, will pose a significant hurdle to the expansion of the Lactoferrin Market. The high prices connected with lactoferrin will further stymie market expansion. Increased government attempts to promote breastfeeding will also slow the growth rate of the Lactoferrin Market.

Global Lactoferrin Market: Segmentation Analysis

The Global Lactoferrin Market is Segmented Based on Function, Application, And Geography.

Lactoferrin Market, By Function

• Iron Absorption
• Anti-Inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

Based on Function, the market is segmented into Iron Absorption, Anti-Inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, and Antioxidant. The iron absorption segment generated the most revenue in 2022 and is predicted to continue its lead throughout the projection period. Iron deficiency frequently results in anemia, which affects around 30% of the world's population. Lactoferrin has been a critical remedy for anemia because of its high bioavailability and capacity to enhance serum ferritin levels by five times when compared to other iron sources. According to the WHO, anemia affects about 1.62 billion people worldwide, with pre-school-aged children having the highest incidence, accounting for 47.4% of the total afflicted population.

Lactoferrin Market, By Application

• Food & Beverages
• Infant Formula
• Sports & Functional Foods
• Pharmaceuticals
• Personal Care Products
• Animal Feed

Based on Application, the market is segmented into Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, and Animal Feed. In 2022, the baby formula category led the Lactoferrin Market, accounting for the biggest revenue share. From 2023 to 2030, the category is predicted to grow at a stable CAGR. The increased number of clinical studies supporting baby formula integration with lactoferrin, as well as changing consumer dynamics towards newborn supplemental meals, are expected to drive demand. The demand for newborn nourishment is primarily from developed economies, owing to high disposable money, hectic work schedules, and increased rates of iron deficiency in newborns.

Lactoferrin Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Based on Regional Analysis, the Lactoferrin Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2022, Asia Pacific will be the largest regional market. Throughout the projection period, the regional market is likely to maintain its position. The regional market expansion, led by India, China, and Japan, may be attributable to increased population and consumer purchasing capacity. Unlike most other areas, Asia Pacific contains a substantial number of middle and small firms.

• Furthermore, increased consumer knowledge about newborn nutrition, personal care, and pharmaceutical goods, as well as consumer preference for organic products, are likely to boost the market for lactoferrin in the area. In 2022, North America was the second-largest geographic market for lactoferrin. The United States has emerged as the region's largest market. The rising prevalence of digestive problems has increased product demand across the country.

Key Players

The "Global Lactoferrin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as InVitria, Hilmar Cheese Company, Glanbia plc, Pharming Group NV, APS BioGroup, FrieslandCamina, Synlait Milk Ltd., Ferrin-tech LLC, Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, Milei GmbH.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April 2022, Before it can be licensed for sale on the market, leniolisib, a possible therapy for activated phosphoinositide 3-kinase delta syndrome (APDS) in children, must first go through the regulatory procedure of having an agreed-upon Paediatric Investigation Plan (PIP). Leniolisib has been designated as a Promising Innovative Medicine (PIM), indicating that it may be eligible for the MHRA's Early Access to Medicines Scheme.
• In May 2021, Laura Kelly, Governor of Kansas, and Hilmar Cheese Company, Inc. officials announced that the company has opted to build a brand new, cutting-edge cheese and whey protein production plant in Dodge City, Kansas.
• In September 2020, FrieslandCampina WAMCO completed the acquisition of Nuticima's dairy business. This acquisition has improved Friesl and Campina's production capacity, allowing them to meet the rising demand in Nigeria for powder milk and evaporated milk.
• In October 2020, Milei GmbH reported an increase in lactoferrin manufacturing capacity to 170 tonnes, more than doubling the capacity in 2019. The net investment will be USD 18.3 million.
• In September 2020, FrieslandCampina Ingredients said that it would boost its lactoferrin production capacity in Veghel, Netherlands, by 60 metric tonnes by 2022. This will aid the company's strategic growth in the Early Life Nutrition and Adult Nutrition areas. FrieslandCampina Ingredients will be the world's largest manufacturer of lactoferrin, with a new capacity of 70 mt per year.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Lactoferrin Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Lactoferrin Market gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LACTOFERRIN MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL LACTOFERRIN MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL LACTOFERRIN MARKET, BY FUNCTION

• 5.1 Overview
• 5.2 Iron Absorption
• 5.3 Anti-Inflammatory
• 5.4 Intestinal Flora Protection
• 5.5 Antibacterial
• 5.6 Immune Cell Stimulation
• 5.7 Antioxidant

6 GLOBAL LACTOFERRIN MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Food & Beverages
• 6.3 Infant Formula
• 6.4 Sports & Functional Foods
• 6.5 Pharmaceuticals
• 6.6 Personal Care Products
• 6.7 Animal Feed

7 GLOBAL LACTOFERRIN MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL LACTOFERRIN MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 InVitria
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Hilmar Cheese Company
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Glanbia plc
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Pharming Group NV
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 APS BioGroup
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 FrieslandCamina
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Synlait Milk Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Ferrin-tech LLC
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Ingredia SA
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Tatura Milk Industries Ltd.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research